导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 25.94% | 171/1050 |
| 近一周 | -1.30% | 518/1104 |
| 近一月 | -4.90% | 762/1103 |
| 近一季 | -21.98% | 1005/1092 |
| 近半年 | 15.78% | 202/1070 |
| 近一年 | 29.67% | 170/1018 |
| 近两年 | 97.94% | 216/926 |
| 近三年 | 71.61% | 162/834 |
| 成立以来 | 91.19% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.69% 215/1070 |
70.75% 139/1101 |
- - |
- - |
| 2025 | 50.34% 191/1065 |
-1.82% 902/1014 |
9.71% 112/1038 |
41.65% 163/1050 |
-1.47% 531/1065 |
| 2024 | -3.88% 671/1011 |
7.06% 58/960 |
1.45% 217/983 |
-4.79% 974/991 |
-7.05% 783/1011 |
| 2023 | -22.10% 727/952 |
-5.64% 806/880 |
-3.49% 417/895 |
-9.68% 579/915 |
-5.29% 540/952 |
| 2022 | -29.98% 628/867 |
-17.16% 370/773 |
4.48% 549/806 |
-8.65% 176/845 |
-11.45% 812/867 |
| 2021 | 1.30% 340/740 |
-6.50% 400/580 |
21.25% 145/659 |
0.12% 213/704 |
-10.75% 665/740 |
| 2020 | 80.44% 89/554 |
3.53% 90/419 |
27.76% 148/466 |
11.55% 214/517 |
22.30% 95/554 |
| 2019 | 72.28% 30/410 |
30.13% 373/1149 |
0.87% 250/1231 |
18.10% 21/390 |
11.13% 129/410 |
| 2018 | -30.34% 221/349 |
- - |
- - |
- - |
-12.28% 626/1080 |
| 2017 | 15.34% 101/285 |
- - |
- - |
- - |
- - |
| 2016 | -19.27% 114/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 摩根安全战略股票A VS. 东吴新产业精选股票A(580008) |